Under construction – not a live service

Skip to content

Frontlight Research

Institution

Tominaga hospital

Osaka, JapanhealthcareWebsite

Also known as: Medical Corporation Kotobukikai Tominaga hospital · 富永病院

5running trials
6closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326· Phase 3· Source
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
NCT04194944· Phase 3· Source
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
NCT03887455· Phase 3· Source
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
NCT03432286· Phase 3· Source
Active, not recruiting
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
NCT03157128· Phase 1/2· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
NCT06323928· Phase 2· Source
Completed
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· Phase 2· Source
Completed
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
NCT05064371· Phase 3· Source
Completed
Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
NCT04921384· Phase 3· Source
Completed
A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
NCT04437433· Phase 3· Source
Completed
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
NCT03832998· Phase 3· Source

Trial sites

Conditions

Diseases this institution publishes on or runs trials for.

Migraine25 works · 7 trials

Institution data: ROR 0007tes83 (CC0-1.0)Updated 10 Nov 2026

Report an error

Under construction, not live – Tominaga hospital: trials and research groups – Frontlight Research